共 50 条
- [31] Second-line erlotinib for non-small-cell lung cancer Reply LANCET ONCOLOGY, 2012, 13 (04): : E142 - E142
- [32] NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer LANCET ONCOLOGY, 2011, 12 (08): : 728 - 730
- [33] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure Cancer Chemotherapy and Pharmacology, 2009, 64 : 1123 - 1127
- [35] Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases Journal of Neuro-Oncology, 2008, 90 : 31 - 33
- [38] Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer LUNG CANCER-TARGETS AND THERAPY, 2011, 2 : 1 - 9
- [39] Special Report: Policy Erlotinib for the treatment of non-small-cell lung cancer LANCET ONCOLOGY, 2009, 10 (01): : 15 - 16